Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy

Clinical trial NCT02348320 · COMPLETED

Trial details

NCT number: NCT02348320
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Triple Negative Breast Cancer Triple-Negative Breast Cancer Triple Negative Breast Neoplasms

Start date: 2015-06-17
Primary completion: 2020-03-12
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.